학술논문
Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia January 2023 23(1):e51-e58
Subject
Language
ISSN
2152-2650